Nikko Asset Management Americas, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Nikko Asset Management Americas, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$62.15 - $90.32 $11.4 Million - $16.5 Million	-182,704 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$61.35 - $90.47 $1.47 Million - $2.17 Million	23,973 Added 15.1%	182,704 $12.1 Million
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $6.96 Million - $13.6 Million	158,731 New	158,731 $12.2 Million

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.06B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.